Cash & equivalents decreased 16.9%
Cash & equivalents changed -16.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -16.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +2376 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed +387.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +534.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +112596 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed -53.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +199.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -16.7% from the comparable as-filed period.
Debt changed -6.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed -8.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.